Hines will continue doing business under its current brand name and Steve McClung, previously Global Excel’s Senior Vice President of Technology & Innovation, has been named the new CEO.
“Hines has built a very strong reputation providing case, utilisation and disease management services focused on the US market,” said Reg Allatt, CEO of Global Excel. “Moving forward we will continue our strategy of expanding the depth of our risk management services, our client base, as well as our geographic presence through continued profitable organic growth and qualified acquisitions.”
Widening the range of services in the US market
McClung added: “This partnership widens the range of services we offer in the US healthcare market and fully compliments the services currently offered by our US-based subsidiary, Opus MedStrategies Inc. I’m looking forward to working together with the excellent team at Hines, learning about the unique needs of their clients and how we can enhance the value of the services we currently provide, building on the history of strong relationships and customer focus they have established over the years.”